Emilija Nemickaite

Ms. Emilija Nemickaite

Department of Drug Technology and Social Pharmacy, Lithuanian University of Health Sciences, Kaunas, Kauno Miestas, Lithuania
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2025 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
ENEmilija Nemickaite
Emilija Nemickaite
UZUgne Zlabiene
Ugne Zlabiene
Agnė MazurkevičiūtėAgnė Mazurkevičiūtė
Agnė Mazurkevičiūtė
MMMindaugas Marksa
Mindaugas Marksa
Jurga BernatonieneJurga Bernatoniene
Jurga Bernatoniene
Background/Objectives: Chitosan–alginate microcapsules were produced to encapsulate bioactive compounds from Artemisia annua L. extract (apigenin, luteolin) and cannabidiol (CBD). The study aimed to optimize emulsion composition and encapsulation parameters for potential applications in food supplements and pharmaceuticals. Methods: A water-in-oil-in-water (W/O/W) emulsion and a modified coacervation extrusion technique were employed. The study was conducted in two phases using response surface methodology. Key metrics included encapsulation efficiency (EE), yield (EY), cumulative release in vitro, and physicochemical and morphological properties, analyzed via scanning electron microscopy (SEM), Fourier transform infrared spectroscopy (FT-IR), high-performance liquid chromatography with a diode array detector (HPLC-DAD), and gas chromatography with flame ionization detection (GC-FID). Results: The optimal conditions were identified as 0.1% Tween 20, 3.8% Span 80, 3.8% CBD, 19.9% A. annua L. extract, 1.5% outer-phase Tween 20, 48.5% sodium alginate, 200 rpm stirring for 30 min, and a 0.05 mL/min flow rate. The EE values were 80.32 ± 4.11% for CBD, 88.13 ± 3.13% for apigenin, and 88.41 ± 4.17% for luteolin, with respective cumulative releases of 77.18 ± 4.4%, 75.12 ± 4.81%, and 75.32 ± 4.53%. Conclusions: The developed microcapsules demonstrated high encapsulation efficiency and controlled release, highlighting their potential for further development in food supplements and pharmaceuticals. Future studies should focus on refining the formulation for improved bioavailability and stability.

23 May 2024 in Molecules
Verified
Journal Article
Open access
PDF file
Jurga BernatonieneJurga Bernatoniene
Jurga Bernatoniene
ENEmilija Nemickaite
Emilija Nemickaite
Daiva MajieneDaiva Majiene
Daiva Majiene
MMMindaugas Marksa
Mindaugas Marksa
DKDalia Marija Kopustinskiene
Dalia Marija Kopustinskiene
Glioblastoma, the most aggressive and challenging brain tumor, is a key focus in neuro-oncology due to its rapid growth and poor prognosis. The C6 glioma cell line is often used as a glioblastoma model due to its close simulation of human glioma characteristics, including rapid expansion and invasiveness. Alongside, herbal medicine, particularly Artemisia spp., is gaining attention for its anticancer potential, offering mechanisms like apoptosis induction, cell cycle arrest, and the inhibition of angiogenesis. In this study, we optimized extraction conditions of polyphenols from Artemisia annua L. and Artemisia vulgaris L. herbs and investigated their anticancer effects in silico and in vitro. Molecular docking of the main phenolic compounds of A. annua and A. vulgaris and potential target proteins, including programmed cell death (apoptosis) pathway proteins proapoptotic Bax (PDB ID 6EB6), anti-apoptotic Bcl-2 (PDB ID G5M), and the necroptosis pathway protein (PDB ID 7MON), mixed lineage kinase domain-like protein (MLKL), in complex with receptor-interacting serine/threonine-protein kinase 3 (RIPK3), revealed the high probability of their interactions, highlighting the possible influence of chlorogenic acid in modulating necroptosis processes. The cell viability of rat C6 glioma cell line was assessed using a nuclear fluorescent double-staining assay with Hoechst 33342 and propidium iodide. The extracts from A. annua and A. vulgaris have demonstrated anticancer activity in the glioblastoma model, with the synergistic effects of their combined compounds surpassing the efficacy of any single compound. Our results suggest the potential of these extracts as a basis for developing more effective glioblastoma treatments, emphasizing the importance of further research into their mechanisms of action and therapeutic applications.

5 February 2020 in Technium Social Sciences Journal
Verified
Journal Article
Open access
PDF file
ŽNŽivilė Nemickienė
Živilė Nemickienė
ENEmilija Nemickaite
Emilija Nemickaite
The present research analyses one out of multiple challenges the first-year students face during their transition to academic life, namely, the first-year students’ work and rest balance. The balance, if managed wisely, might become a strong enabler to a successful transition to university life. The study analyses a series of factors, such as the balance of work and rest of the first-year students, skills of time management and the psychological state during the first months at university. The study employs a comparative analysis to evaluate the average hours of work and rest per week of a first-year student comparing with the planned time. The data of students’ work and rest balance was collected from the diary they were asked to record for two months. A focus group was comprised of twenty-five respondents of finance, twelve students of language and three of health science study programs at Lithuanian universities.

20 August 2026 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
ENEmilija Nemickaite
Emilija Nemickaite
PTPooja Ashok Todke
Pooja Ashok Todke
VCVaidotas Cicenas
Vaidotas Cicenas
EJElena Jasiuniene
Elena Jasiuniene
MMMindaugas Marksa
Mindaugas Marksa
Jurga BernatonieneJurga Bernatoniene
Jurga Bernatoniene
Background: Three-dimensional printing (3DP) is rapidly advancing personalised medicine, yet systematic performance comparison with conventional manufacturing remains limited, particularly for plant-based formulations. Methods: This study compared tablets containing plant-based APIs (cannabidiol, apigenin, and luteolin) produced via conventional hot moulding and semi-solid extrusion (SSE) 3DP. The formulations were evaluated for physicochemical, mechanical, rheological, structural, and drug-release properties. Results: Both manufacturing methods produced tablets with comparable dimensions and mass; however, pronounced formulation-dependent differences were observed in mechanical strength, rheology, and microstructure. The molecular modelling predictions were consistent with the experimental findings. Agar–pectin exhibited the strongest predicted polymer–polymer and polymer–API interactions, including multiple hydrogen bonds, and formed a comparatively dense and cohesive matrix associated with slower API release. In contrast, the weaker interactions predicted for gelatine–pectin were associated with a less cohesive and more porous matrix that facilitated medium penetration, API diffusion, and drug release. SSE printlets generally exhibited greater porosity and more heterogeneous internal architectures than moulded tablets, resulting in enhanced drug release of approximately 95%. Micro-CT analysis provided important structural confirmation; API incorporation increased the void volume of gelatine–pectin printlets from 1.15% to 8.77%, demonstrating that disruption of polymer interactions contributed to pore formation and enhanced molecular diffusion. The observed release behaviour correlated with predicted molecular interactions and experimentally observed microstructural features, where increased porosity and weaker polymer–API interactions facilitated enhanced drug diffusion. Conclusions: Overall, SSE-3DP outperformed conventional moulding, demonstrating superior tunability and performance. This work provides a mechanistically informed strategy for designing plant-based, personalised natural products using 3DP technologies.